Skip to content
Home
Company Focus
Our Technology
Company Status
Menu
Home
Company Focus
Our Technology
Company Status
Company Status
A Phase 2b clinical proof-of-concept trial in patients with spinal cord injury will be initiated following the completion of the ongoing financing.